Align Technology, Inc.

NasdaqGS ALGN

Align Technology, Inc. Debt to Equity Ratio for the Trailing 12 Months (TTM) ending September 30, 2024: 0.03

Align Technology, Inc. Debt to Equity Ratio is 0.03 for the Trailing 12 Months (TTM) ending September 30, 2024, a 7.65% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Align Technology, Inc. Debt to Equity Ratio for the Trailing 12 Months (TTM) ending September 30, 2023 was 0.03, a -9.61% change year over year.
  • Align Technology, Inc. Debt to Equity Ratio for the Trailing 12 Months (TTM) ending September 30, 2022 was 0.03, a 59.75% change year over year.
  • Align Technology, Inc. Debt to Equity Ratio for the Trailing 12 Months (TTM) ending September 30, 2021 was 0.02, a -3.34% change year over year.
  • Align Technology, Inc. Debt to Equity Ratio for the Trailing 12 Months (TTM) ending September 30, 2020 was 0.02, a -49.60% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Loading...
SV Wall Street
NasdaqGS: ALGN

Align Technology, Inc.

CEO Mr. Joseph M. Hogan
IPO Date Jan. 30, 2001
Location United States
Headquarters 410 North Scottsdale Road
Employees 21,690
Sector Healthcare
Industries
Description

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

Similar companies

PODD

Insulet Corporation

USD 284.70

2.23%

INSP

Inspire Medical Systems, Inc.

USD 192.00

-2.73%

TMDX

TransMedics Group, Inc.

USD 74.57

3.37%

INMD

InMode Ltd.

USD 17.21

-0.35%

DXCM

DexCom, Inc.

USD 88.78

1.51%

EW

Edwards Lifesciences Corporation

USD 72.10

1.08%

SYK

Stryker Corporation

USD 399.09

1.71%

ABT

Abbott Laboratories

USD 132.06

2.29%

MDT

Medtronic plc

USD 91.69

0.79%

NARI

Inari Medical, Inc.

USD 79.89

0.05%

TNDM

Tandem Diabetes Care, Inc.

USD 36.69

1.94%

PEN

Penumbra, Inc.

USD 265.94

1.46%

BSX

Boston Scientific Corporation

USD 104.97

1.38%

StockViz Staff

February 7, 2025

Any question? Send us an email